D
David J. Rosenman
Researcher at Mayo Clinic
Publications - 8
Citations - 392
David J. Rosenman is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Hospital medicine & Health care. The author has an hindex of 5, co-authored 8 publications receiving 353 citations. Previous affiliations of David J. Rosenman include Massachusetts Institute of Technology & Seattle Children's.
Papers
More filters
Journal ArticleDOI
Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period
David J. Rosenman,Furman S. McDonald,Jon O. Ebbert,Patricia J. Erwin,Matthew L. LaBella,Victor M. Montori +5 more
TL;DR: Assessment of the clinical consequences of preoperatively continuing versus withholding preoperative ACEI/ARAs in patients treated chronically with these agents found that preoperative administration of ACEI or ARA increases intraoperative hypotension.
Journal ArticleDOI
Eight Years of the Mayo International Health Program: What an International Elective Adds to Resident Education
TL;DR: The MIHP provides the structure and funding to enable residents from a variety of specialties to participate in international electives and obtain an identifiable set of unique, valuable educational experiences likely to shape them into better physicians.
Journal ArticleDOI
Hospital medicine fellowships: works in progress.
TL;DR: An overview of hospitalist fellowships is provided, the choices for trainees in selecting a fellowship, and the challenges for institutions in developing a new fellowship are explored.
Journal Article
Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel.
Nadir Arber,Hanina Hibshoosh,W. Yasui,Alfred I. Neugut,A. Hibshoosh,Yao Yao,Alessandro Sgambato,Hirofumi Yamamoto,I. Shapira,David J. Rosenman,I. Fabian,I. B. Weinstein,E. Tahara,Peter R. Holt +13 more
TL;DR: Cell cycle abnormalities are early and important events in the multistep process of small bowel tumorigenesis, thus resembling colorectal carcinogenesis, and deregulated expression of G1 proteins may perturb cell cycle control in benign adenomas of the small bowel and thereby enhance tumor progression.
Journal ArticleDOI
In‐room display of day and time patient is anticipated to leave hospital: A “discharge appointment”
Dennis M. Manning,Karyl J. Tammel,R. Nicole Blegen,Lori A. Larson,Fay L. Steffens,David J. Rosenman,William C. Mundell,James M. Naessens,Roger Resar,Jeanne M. Huddleston +9 more
TL;DR: With a program for in-room display of a DA in various hospital units, more than half the patients had a DA set, and most of the DA patients departed from the care unit within 30 minutes of the appointed time.